HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

rovelizumab

a humanized monoclonal antibody that recognizes CD11/CD18 integrins
Also Known As:
HU-23F2G; HU23F2G; Leukarrest
Networked: 7 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Chronos, Nicolas A F: 1 article (10/2002)
2. Faxon, David P: 1 article (10/2002)
3. Gibbons, Raymond J: 1 article (10/2002)
4. Gurbel, Paul A: 1 article (10/2002)
5. HALT-MI Investigators: 1 article (10/2002)
6. Sheehan, Florence: 1 article (10/2002)
7. Becker, Kyra J: 1 article (01/2002)
8. Breisblatt, W M: 1 article (09/2001)
9. Clements, I P: 1 article (09/2001)
10. Feldman, R L: 1 article (09/2001)

Related Diseases

1. Myocardial Infarction
2. Chronic Progressive Multiple Sclerosis
3. Infarction (Infarctions)
4. Ischemic Stroke
5. Stroke (Strokes)

Related Drugs and Biologics

1. Integrins
2. rovelizumab
3. Monoclonal Antibodies
4. Antibodies
5. enlimomab

Related Therapies and Procedures

1. Intravenous Infusions